Metraipolis › archive › dc_309dbbf9d2ac

CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders — Europe PMC PMID:41180498

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41180498
DOI
10.3389/fncel.2025.1681891
License (as archived)
solo-consultazione
Archived
2026-11-09T06:45:06.389Z
SHA-256 of the archived text
97377ed62247289d3cf02c3f97909a1259a44f237d92967628ba70e1c093cb87
Stable URL of this page
https://metraipolis.com/documento/dc_309dbbf9d2ac

How to cite

CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders — Europe PMC PMID:41180498 — Europe PMC (en), https://europepmc.org/article/MED/41180498 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_309dbbf9d2ac (Metraipolis archive dc_309dbbf9d2ac, sha256 97377ed62247289d3cf02c3f97909a1259a44f237d92967628ba70e1c093cb87)
BibTeX
@misc{dc309dbbf9d2ac,
  title = {CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders — Europe PMC PMID:41180498},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41180498},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_309dbbf9d2ac; sha256 97377ed62247289d3cf02c3f97909a1259a44f237d92967628ba70e1c093cb87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41180498. Agents can read the archived copy with the MCP tool read_document.